Company intelligence / Profile preview

AIMS BioScience

Seoul, Seoul Special City, South Koreaaimsbiosci.com ↗

Ownership: Private
Development stage: Other

Overview

AIMS BioScience is a Korea-based consulting firm specializing in new drug development strategy, clinical pharmacology, modeling & simulation for global pharmaceutical companies and biotech ventures. The company has supported over 150 clients with more than 300 projects since its founding in 2019. It leverages deep expertise in regulatory science, clinical trial design, market access strategy, and advanced digital health infrastructure to accelerate client programs from early discovery through market entry

Modalities: Small moleculeBiologicCell therapyGene therapy
Industry: Consulting

Partnerships

Collaborates with top-tier investigators, leading CROs in Korea/global markets; no specific partner names disclosed

Beyond the preview

Go deeper on AIMS BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIMS BioScience.

Explore the full profile